{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:14:21Z","timestamp":1780488861988,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T00:00:00Z","timestamp":1650153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018810","name":"OTC Self-Medication Promotion Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["20K10053"],"award-info":[{"award-number":["20K10053"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["20K18604"],"award-info":[{"award-number":["20K18604"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.biopha.2022.112991","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T17:21:19Z","timestamp":1650561679000},"page":"112991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Lansoprazole and zoledronate delays hard tissue healing of tooth extraction sockets in dexamethasone-treated mice"],"prefix":"10.1016","volume":"150","author":[{"given":"Reina","family":"Yoshioka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Mine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Nikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.112991_bib1","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.3390\/ijms20205203","article-title":"Adverse effects of proton pump inhibitors-evidence and plausibility","volume":"20","author":"Fossmark","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2022.112991_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.curtheres.2017.01.003","article-title":"A case of severe iron deficiency anemia associated with long-term proton pump inhibitor use","volume":"84","author":"Dado","year":"2017","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.biopha.2022.112991_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/j.gastro.2017.04.047","article-title":"Complications of proton pump inhibitor therapy","volume":"153","author":"Vaezi","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2022.112991_bib4","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.biopha.2022.112991_bib5","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joms.2009.10.010","article-title":"Osteonecrosis of the jaw in a patient on denosumab","volume":"68","author":"Aghaloo","year":"2010","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.biopha.2022.112991_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10549-010-0866-3","article-title":"Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer","volume":"122","author":"Guarneri","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.biopha.2022.112991_bib7","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.biopha.2022.112991_bib8","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1007\/s00198-017-4132-y","article-title":"Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users","volume":"28","author":"Eiken","year":"2017","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.biopha.2022.112991_bib9","article-title":"Mandibular osteonecrosis associated with Antacid Therapy (Esomeprazole)","volume":"6","author":"Marconcini","year":"2019","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"10.1016\/j.biopha.2022.112991_bib10","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/jbmr.379","article-title":"Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat","volume":"26","author":"Aghaloo","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.biopha.2022.112991_bib11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2353\/ajpath.2010.090592","article-title":"Bisphosphonates cause osteonecrosis of the jaw-like disease in mice","volume":"177","author":"Bi","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2022.112991_bib12","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/jbmr.1894","article-title":"Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice","volume":"28","author":"Kang","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.biopha.2022.112991_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bone.2013.05.013","article-title":"Chemotherapeutic and antiresorptive combination therapy suppressed lymphangiogenesis and induced osteonecrosis of the jaw-like lesions in mice","volume":"56","author":"Kuroshima","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.biopha.2022.112991_bib14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s00223-021-00916-2","article-title":"Occlusal trauma and bisphosphonate-related osteonecrosis of the jaw in mice","volume":"110","author":"Mine","year":"2022","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.biopha.2022.112991_bib15","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jbmr.37","article-title":"Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice","volume":"25","author":"Kikuiri","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.biopha.2022.112991_bib16","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s00223-012-9649-7","article-title":"Technetium-99 conjugated with methylene diphosphonate ameliorates ovariectomy-induced osteoporotic phenotype without causing osteonecrosis in the jaw","volume":"91","author":"Zhao","year":"2012","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.biopha.2022.112991_bib17","doi-asserted-by":"crossref","first-page":"24562","DOI":"10.1038\/srep24562","article-title":"Naringin ameliorates bone loss induced by sciatic neurectomy and increases Semaphorin 3A expression in denervated bone","volume":"6","author":"Ma","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.112991_bib18","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bone.2019.03.031","article-title":"Vasculature submucosal changes at early stages of osteonecrosis of the jaw (ONJ)","volume":"123","author":"Gkouveris","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.biopha.2022.112991_bib19","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1200\/JCO.19.01186","article-title":"Medication-related osteonecrosis of the jaw: MASCC\/ISOO\/ASCO clinical practice guideline","volume":"3725","author":"Yarom","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2022.112991_bib20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00774-016-0810-7","article-title":"Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw","volume":"35","author":"Japanese Allied Committee on Osteonecrosis of the Jaw","year":"2017","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.biopha.2022.112991_bib21","doi-asserted-by":"crossref","first-page":"R247","DOI":"10.1530\/ERC-12-0400","article-title":"Effects of tyrosine kinase inhibition on bone metabolism: untargeted consequences of targeted therapies","volume":"21","author":"Alem\u00e1n","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.biopha.2022.112991_bib22","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.4317\/medoral.23191","article-title":"Review and update on drugs related to the development of osteonecrosis of the jaw","volume":"25","author":"Eguia","year":"2020","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"10.1016\/j.biopha.2022.112991_bib23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.yapd.2017.03.006","article-title":"Effects of inhaled corticosteroids on growth, bone metabolism, and adrenal function","volume":"64","author":"Wolfgram","year":"2017","journal-title":"Adv. Pediatr."},{"key":"10.1016\/j.biopha.2022.112991_bib24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12020-011-9580-0","article-title":"Glucocorticoid-induced osteonecrosis","volume":"41","author":"Weinstein","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.biopha.2022.112991_bib25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1620\/tjem.246.257","article-title":"Risk of delayed healing of tooth extraction wounds and osteonecrosis of the jaw among patients treated with potential immunosuppressive drugs: a retrospective Cohort Study","volume":"246","author":"Hayashi","year":"2018","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.biopha.2022.112991_bib26","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1158\/1078-0432.CCR-13-0042","article-title":"IL-17-mediated M1\/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws","volume":"19","author":"Zhang","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2022.112991_bib27","article-title":"Biologic and pathologic aspects of osteocytes in the setting of medication-related osteonecrosis of the jaw (MRONJ)","volume":"153","author":"Aguirre","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.biopha.2022.112991_bib28","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1080\/003655201750422585","article-title":"Long-term omeprazole treatment suppresses body weight gain and bone mineralization in young male rats","volume":"36","author":"Cui","year":"2001","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2022.112991_bib29","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.nut.2012.07.014","article-title":"Can 2-oxoglutarate prevent changes in bone evoked by omeprazole?","volume":"29","author":"Dobrowolski","year":"2013","journal-title":"Nutrition"},{"key":"10.1016\/j.biopha.2022.112991_bib30","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3389\/fphar.2020.00583","article-title":"Supplement With calcium or alendronate suppresses osteopenia due to long term rabeprazole treatment in female mice: influence on bone TRAP and osteopontin levels","volume":"11","author":"Shaalan","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112991_bib31","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archinternmed.2011.20","article-title":"Proton pump inhibitor use and the antifracture efficacy of alendronate","volume":"171","author":"Abrahamsen","year":"2011","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.biopha.2022.112991_bib32","article-title":"Preclinical models of medication-related osteonecrosis of the jaw (MRONJ)","volume":"153","author":"Aguirre","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.biopha.2022.112991_bib33","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tripleo.2007.08.040","article-title":"Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology","volume":"105","author":"Bedogni","year":"2008","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.biopha.2022.112991_bib34","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12967-017-1230-8","article-title":"Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis","volume":"15","author":"Gross","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2022.112991_bib35","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/jgh.14040","article-title":"Oral microbiome alterations of healthy volunteers with proton pump inhibitor","volume":"33","author":"Mishiro","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2022.112991_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jebdp.2020.101466","article-title":"Systemic intake of proton pump inhibitors and selective serotonin reuptake inhibitors may be associated with implant failure","volume":"20","author":"Cheng","year":"2020","journal-title":"J. Evid. Based Dent. Pract."},{"key":"10.1016\/j.biopha.2022.112991_bib37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/cre2.495","article-title":"Association between proton pump inhibitors and periodontal disease severity","volume":"8","author":"Chawla","year":"2022","journal-title":"Clin. Exp. Dent. Res."},{"key":"10.1016\/j.biopha.2022.112991_bib38","article-title":"Alendronate and omeprazole in combination reduce angiogenic and growth signals from osteoblasts","volume":"14","author":"Kr\u00fcger","year":"2021","journal-title":"Bone Rep."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222003808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222003808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:34:25Z","timestamp":1780486465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222003808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":38,"alternative-id":["S0753332222003808"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112991","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lansoprazole and zoledronate delays hard tissue healing of tooth extraction sockets in dexamethasone-treated mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112991"}}